Press release
Analysis and Opportunity Assessment in Migraine Drugs Market till 2026 by Top Key Players: Pfizer Inc., Aeriel BioPharma, Alder BioPharmaceuticals Inc., Amgen Inc., Astellas Pharma Inc., IntelGenx Corp., Luitpold Pharmaceuticals
Request Sample for more Professional and Technical insights @
http://bit.ly/2Dootun
Migraine is most common between the ages of 25 and 55 and this ailment is tending to run in family by mean that, approximately 90% cases of migraine cases do have family history for the disease. According to the Migraine Research Foundation, Migraine is the third most widespread neurological disease, affecting 39 million children, women, and men in the U.S. and 1 billion globally. Thus, growing number of people having migraine and high probabilities of occurrence of this illness along with its hereditary phenomena is anticipated to boost the Migraine Drugs Market in the forecast period. In addition, improved awareness for the migraine drugs and treatments, coupled with technological advancement for the manufacturing of anti-migraine drugs are other factors anticipated to propel the market growth.
Increasing occurrences of migraine attack is anticipated to bolster growth for migraine drugs Migraine Drugs Market.
North America region observed to dominate the market due to rising incidences of migraine attacks and the high demand for drugs.
Key players of Migraine Drugs Market:
• Pfizer Inc.
• Aeriel BioPharma
• Alder BioPharmaceuticals Inc.
• Amgen Inc., Astellas Pharma Inc.
• IntelGenx Corp.
• Luitpold Pharmaceuticals
• Teva Pharmaceutical Industries LTD
• AstraZeneca plc
• GlaxoSmithKline plc
• Endo International plc
• CoLucid Pharmaceuticals Inc.
• Johnson & Johnson
• Valeant Pharmaceuticals International, Inc.
• Zogenix Inc.
• Abbott Laboratories
• Aegis Therapeutics, LLC.
• WINSTON PHARMACEUTICALS, Inc.
• Kowa Pharmaceuticals America
• Reddy’s Laboratories Ltd.
For 'Queries' related to this research report, Make an Enquiry @
http://bit.ly/2DmFl4y
Migraine Drugs Market is segmented on the basis of drug type, route of administration, distribution channel, and geography.
On the basis of Migraine drug type, the market is segmented into:
• Triptans
• Sumatriptan
• Zolmitriptan
• Rizatriptan
• Frovatriptan
• Others
• Ergot Alkaloids
On the basis of route of administration, the Migraine Drugs Market is segmented into:
• Oral
• Injectable
On the basis of distribution channel, the Migraine Drugs Market is segmented into:
• Hospital Pharmacies
• Online Pharmacies
• Retail Pharmacies
On the basis of geography, North America region is estimated to dominate the Migraine Drugs Market. The high market growth in this region is attributed to factors such as increased healthcare expenditure and convenience of getting specialty migraine drugs. In addition, rising incidence of migraine attacks in U.S. and Canada is anticipated to boost the market growth in this region. According to Migraine Research Foundation, approximately 1 in 4 U.S. families includes a person with migraine disease. Moreover, at every 10 seconds, a person in the U.S. has to visit the emergency room complaining of head ache, and around 1.2 million hospital visits are due to acute migraine attacks. Thus, high incidence rate and growing demand for the drugs to treat or cure the migraine is further anticipated to bolster the market growth in North America.
Browse Full Report with Complete TOC @
https://www.polarismarketresearch.com/industry-analysis/migraine-drugs-market/
About Us:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced and extremely qualified team of experts comprising SMEs, analysts and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers.
Contact Us:
Mr. Neel
Corporate Sales, USA
Polaris Market Research and Consulting
Phone: 1-646-568-9980
Email: sales@polarismarketresearch.com
Web: www.polarismarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Analysis and Opportunity Assessment in Migraine Drugs Market till 2026 by Top Key Players: Pfizer Inc., Aeriel BioPharma, Alder BioPharmaceuticals Inc., Amgen Inc., Astellas Pharma Inc., IntelGenx Corp., Luitpold Pharmaceuticals here
News-ID: 1373978 • Views: …
More Releases from Polaris Market Research & Consulting
Gene Therapy Market Growth Projection: USD 29.01 Billion Valuation by 2035 at 27 …
The quantitative market research report published by Polaris Market Research on Gene Therapy Market aims to educate users with an in-depth understanding of a rapidly growing market. The study details important facts and figures, expert opinions, and major developments across the globe. The research study serves as a vital source of information with the historical data, Gene Therapy Market size, financial data, and projected future growth. All the information presented…
Europe Armor Materials Market to Reach USD 6.09 Billion by 2034, Growing at 7.0% …
Market Size and Share:
Europe Armor Materials Market is currently valued at USD 3.10 billion in 2024 and is anticipated to generate an estimated revenue of USD 6.09 billion by 2034, according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a robust 7% Compound Annual Growth Rate (CAGR) over the forecasted timeframe, 2025 - 2034
Polaris Market Research has introduced the latest market research…
Europe Antibody Specificity Testing Market Projected to Hit USD 433.81 Million b …
The quantitative market research report published by Polaris Market Research on Europe Antibody Specificity Testing Market aims to educate users with an in-depth understanding of a rapidly growing market. The study details important facts and figures, expert opinions, and major developments across the globe. The research study serves as a vital source of information with the historical data, Europe Antibody Specificity Testing Market size, financial data, and projected future growth.…
U.S. Extended Detection and Response (XDR) Market to Reach USD 24.86 Billion by …
The quantitative market research report published by Polaris Market Research on U.S. Extended Detection and Response (XDR) Market aims to educate users with an in-depth understanding of a rapidly growing market. The study details important facts and figures, expert opinions, and major developments across the globe. The research study serves as a vital source of information with the historical data, U.S. Extended Detection and Response (XDR) Market size, financial data,…
More Releases for Migraine
Leading Growth Driver in the Migraine Market Share in 2025: Rising Prevalence Of …
What Market Share dynamics are playing a key role in accelerating the growth of the migraine Market Share?
The migraine Market Share is projected to grow, driven by the rising occurrence of migraines. Migraines, a kind of headache that typically affects one side of the brain and causes intense, throbbing pain or a pulsing sensation, can be managed and relief can be provided via proper treatment. This treatment paves the way…
Emerging Acute Migraine Treatment Market Trend 2025-2034: Innovative CGRP Recept …
How Is the Acute Migraine Treatment Market Projected to Grow, and What Is Its Market Size?
The market size for acute migraine treatment has witnessed substantial growth in the past few years. Forecasts expect it to expand from $2.6 billion in 2024 to $2.91 billion in 2025, boasting a compound annual growth rate (CAGR) of 11.6%. Factors contributing to this growth in the historical period include the rising incidence of migraines,…
Key Influencer in the Migraine Market 2025: Rising Prevalence Of Migraine Drives …
"What Is the Forecasted Market Size and Growth Rate for the Migraine Market?
The migraine market is projected to grow steadily from $1.93 billion in 2024 to $1.97 billion in 2025, at a CAGR of 2.2%. This growth is attributed to the rising prevalence of migraines, growing awareness of treatment options, government initiatives, increased alcohol consumption, and lifestyle changes.
Migraine Market: Expected to grow to $2.25 billion by 2029 at a CAGR…
How Big is Migraine Drugs Market?
In 2022, the Global Migraine Drugs Market soared to USD 10,972.1 million, marking a significant milestone. Projections indicate a promising trajectory, with expectations set for substantial growth, potentially reaching USD 26,618.96 million by 2031. Forecasts for the period between 2024 and 2031 suggest a robust Compound Annual Growth Rate (CAGR) of 12.1% for the migraine drugs market.
The objectives outlined in the report are multifaceted and aimed at offering a comprehensive…
Migraine Therapeutics Market - Relieve the Burden: Empowering Lives through Migr …
Newark, New Castle, USA - new report, titled Migraine Therapeutics Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Migraine Therapeutics market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Migraine Therapeutics market. The report offers an overview of the market, which…
Rise in Prevalence of Migraine Drives the Migraine Drugs Market | Outlook 2025
Migraine is characterized by a recurrent throbbing headache, which affects only one side of the head. It is accompanied by vomiting, nausea and even altered vision in some cases.
The increase in the prevalence of migraine, the rapid increase in the female population and the increased awareness among patients for the treatment and prevention of migraine are driving the growth of the global market for anti-migraine drugs.
Get Access to TOC /…
